EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of Oncology Drug Lag in Japan and South Korea Based on the Interval between the U.S. Approval and the Local Approval

Yoshifumi Tachibana, Jangsoo Yoon, Mamoru Narukawa

Biological and Pharmaceutical Bulletin · 12.01.2025 · 48 (1) · 11-16

DOI: 10.1248/bpb.b24-00555 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 12.01.2025. Verfasst von Yoshifumi Tachibana und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-k…. Hauptthemen laut MEDLINE: Drug Approval, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ApprovalAntineoplastic AgentsNeoplasmsJapanRepublic of KoreaUnited StatesHumansTime FactorsUnited States Food and Drug AdministrationNational Health Programs

Stichwörter der Autor:innen

JapanKoreaanticancer drugdrug lagnational health insuranceoncology

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
  • Nippon Boehringer Ingelheim Co., Ltd., 2-1-1 Osaki, Shinagawa-ku, Tokyo 141-6017, Japan.
  • Life Sciences, LG Chem, 128 Yeoui-daero, Yeongdeungpo-gu, Seoul 07336, Republic of Korea.

Zitieren

APA

Tachibana, Y., Yoon, J., & Narukawa, M. (2025). Comparison of Oncology Drug Lag in Japan and South Korea Based on the Interval between the U.S. Approval and the Local Approval. Biological and Pharmaceutical Bulletin, 48(1), 11-16. https://doi.org/10.1248/bpb.b24-00555

Vancouver

Tachibana Y, Yoon J, Narukawa M. Comparison of Oncology Drug Lag in Japan and South Korea Based on the Interval between the U.S. Approval and the Local Approval. Biological and Pharmaceutical Bulletin. 2025;48(1):11-16. doi:10.1248/bpb.b24-00555

BibTeX
@article{Tachibana2025,
  author = {Tachibana, Yoshifumi and Yoon, Jangsoo and Narukawa, Mamoru},
  title = {Comparison of Oncology Drug Lag in Japan and South Korea Based on the Interval between the U.S. Approval and the Local Approval},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  volume = {48},
  number = {1},
  pages = {11--16},
  doi = {10.1248/bpb.b24-00555}
}
Kostenlos starten →